GlassScriptPhysician profile
Sophia Drinis
NPI 1932175924
$5,696.69
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,605 · 2020: $1,185 · 2021: $589 · 2022: $318.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $4,305.99 | 2019-2022 | |
| Astellas Pharma US INC | $329.66 | 2019-2022 | |
| Boston Scientific Corporation | $219.90 | 2019-2022 | |
| Pfizer INC. | $205.30 | 2019-2021 | |
| Axonics, INC. | $91.45 | 2020-2022 | |
| Endo Pharmaceuticals INC. | $87.25 | 2019-2021 | |
| Medtronic, INC. | $83.01 | 2021-2022 | |
| Urovant Sciences INC | $63.41 | 2021-2022 | |
| Neotract INC. | $53.49 | 2019 | |
| Allergan, INC. | $40.77 | 2020-2021 | |
| Myriad Genetic Laboratories, INC. | $35.88 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.59 | 2021 | |
| Zyla Life Sciences, INC. | $27.78 | 2019 | |
| Laborie Medical Technologies Corp. | $24.76 | 2021 | |
| Janssen Biotech, INC. | $18.83 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $17.08 | 2022 | |
| Medtronic USA, INC. | $15.13 | 2019 | |
| Therapeuticsmd, INC. | $14.36 | 2019 | |
| Abc Home Medical Supply, INC. | $14.12 | 2022 | |
| Myovant Sciences INC. | $13.93 | 2021 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$986.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sophia Drinis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.